TSR2
Pre-rRNA-processing protein TSR2 homolog
Also known as: DT1P1A10, RP1-112K5.2, TSR2_HUMAN, WGG1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969E8
- Gene
- TSR2
- Ensembl
- ENSG00000158526
- Chromosome
- X
- Canonical length
- 191 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
The protein encoded by this gene appears to repress the transcription of NF-kappaB and may be involved in apoptosis. Defects in this gene are a cause of Diamond-Blackfan anemia. [provided by RefSeq, Oct 2016]
Canonical amino-acid sequenceUniProt
191 residues, UniProt reviewed canonical sequence.
>Q969E8|TSR2
1 MAGAAEDARA LFRAGVCAAL EAWPALQIAV ENGFGGVHSQ EKAKWLGGAV EDYFMRNADL
61 ELDEVEDFLG ELLTNEFDTV VEDGSLPQVS QQLQTMFHHF QRGDGAALRE MASCITQRKC
121 KVTATALKTA RETDEDEDDV DSVEEMEVTA TNDGAATDGV CPQPEPSDPD AQTIKEEDIV
181 EDGWTIVRRK KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 62 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 62 nTPM
- midbrain: 57 nTPM
- amygdala: 54 nTPM
- basal ganglia: 53 nTPM
- hypothalamus: 48 nTPM
- hippocampal formation: 47 nTPM
Single-cell type
- oocytes: 152 nCPM
- cytotrophoblasts: 119 nCPM
- epididymal principal cells: 115 nCPM
- migrating cytotrophoblasts: 103 nCPM
- esophageal apical cells: 97 nCPM
- syncytiotrophoblasts: 91 nCPM
Immune cell
- naive B-cell: 47 nTPM
- memory B-cell: 45 nTPM
- naive CD4 T-cell: 43 nTPM
- T-reg: 41 nTPM
- gdT-cell: 36 nTPM
- memory CD4 T-cell: 34 nTPM
Brain region
- hypothalamus: 50 nTPM
- thalamus: 47 nTPM
- amygdala: 47 nTPM
- spinal cord: 46 nTPM
- basal ganglia: 44 nTPM
- medulla oblongata: 43 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TSR2.
Disease | AllUniProt
Conditions TSR2 is implicated in, by any mechanism.
- Diamond-Blackfan anemia 14, with mandibulofacial dysostosis (DBA14) MIM:300946
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 102 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Diamond-Blackfan anemia 14 with mandibulofacial dysostosis
- Diamond-Blackfan anemia 15 with mandibulofacial dysostosis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.8
- gnomAD missense Z
- 0.99
- DepMap mean gene effect
- -1.6
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- LSU-rRNA)
- maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA
- 5.8S rRNA
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pre-rRNA-processing protein TSR2
- Pre-rRNA-processing protein TSR2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TSR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSR2 as an antibody target. Whether an autoantibody or antibody against TSR2 could matter depends on whether native TSR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSR2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TSR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...